| 92.92 Data as of Jun 06 |  +2.11 / +2.32%Today’s Change | 81.82 Today|||52-Week Range 119.54 | -0.87% Year-to-Date |
| Celgene Presents Data at ASCO - Analyst Blog Jun 05 / Zacks.com | Omeros Files CTA for aHUS Candidate - Analyst Blog May 29 / Zacks.com |
| Encouraging data from Bristol-Myers - Analyst Blog Jun 05 / Zacks.com | Encouraging Data from Alkermes - Analyst Blog May 29 / Zacks.com |
| CHMP Backs Celgene's Pomalyst - Analyst Blog Jun 03 / Zacks.com | Amgen-Astellas Collaborate - Analyst Blog May 29 / Zacks.com |
| Biogen Delays EU Launch of Tecfidera - Analyst Blog May 31 / Zacks.com | EU Approval for Bayer/JNJ's Xarelto - Analyst Blog May 28 / Zacks.com |
| Analysts' Actions: ALXN CLWR MS NWE TIF May 31 / TheStreet.com | Priority FDA Review for Celgene's Abraxane - Analyst Blog May 24 / Zacks.com |
| Previous close | 90.81 |
| Today’s open | 90.59 |
| Day’s range | -- - -- |
| Volume | 1,437,876 |
| Average volume (3 months) | 1,509,046 |
| Market cap | $17.7B |
| Dividend yield | -- |
| Earnings growth (last year) | +40.66% |
| Earnings growth (this year) | +38.89% |
| Earnings growth (next 5 years) | +23.60% |
| Revenue growth (last year) | +41.93% |
| P/E ratio | 64.1 |
| Price/Sales | 15.92 |
| Price/Book | 8.97 |
| Today’s change | Today’s % change | |
|---|---|---|
| SHPGShire PLC | +0.21 | +0.21% |
| VRTXVertex Pharmaceutica... | +1.07 | +1.39% |
| ZTSZoetis Inc | -0.09 | -0.28% |
| ACTActavis Inc | +1.66 | +1.38% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.68 |
| Annual revenue (last year) | $1.1B |
| Annual profit (last year) | $254.8M |
| Net profit margin | 22.73% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer, Treasurer & Director Leonard Bell, MD |
Chief Global Operations Officer & Executive VP Stephen P. Squinto, PhD |
Corporate headquarters Cheshire, Connecticut |
.
